Metraipolis › archive › dc_50210cd32370

Financial Toxicity Associated with Biological Medicines: A Scoping Review — Europe PMC PMID:41933435

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41933435
DOI
10.1002/cpt.70278
License (as archived)
solo-consultazione
Archived
2026-11-03T09:51:49.886Z
SHA-256 of the archived text
5e21c29a7e611e12ebcbcf82068f6fe29a3bd994c3825b9292281808821e4597
Stable URL of this page
https://metraipolis.com/documento/dc_50210cd32370

How to cite

Financial Toxicity Associated with Biological Medicines: A Scoping Review — Europe PMC PMID:41933435 — Europe PMC (en), https://europepmc.org/article/MED/41933435 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_50210cd32370 (Metraipolis archive dc_50210cd32370, sha256 5e21c29a7e611e12ebcbcf82068f6fe29a3bd994c3825b9292281808821e4597)
BibTeX
@misc{dc50210cd32370,
  title = {Financial Toxicity Associated with Biological Medicines: A Scoping Review — Europe PMC PMID:41933435},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41933435},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_50210cd32370; sha256 5e21c29a7e611e12ebcbcf82068f6fe29a3bd994c3825b9292281808821e4597},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41933435. Agents can read the archived copy with the MCP tool read_document.